A comparison of the safety and efficacy of oral antiocoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy

Thrombosis and Haemostasis

Volumn 84, Issue 5, 2000, Pages 805-810

  Palareti, G ^a   Legnani, C ^a   Lee, A ^a   Manotti, C ^a   Hirsh, J ^a   D'Angelo, A ^a   Pengo, V ^a   Moia, M ^a   Coccheri, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cancer; DVT; Oral anticoagulation; Safety

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; COUMARIN ANTICOAGULANT; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CANCER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0033708930     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614120     Document Type: Article

References (17)

1. Antithrombotic therapy for venous thromboembolic disease
2. Current concepts: Management of anticoagulation before and after elective surgery
3. Anticoagulants, venous thromboembolism and the cancer patient
4. Anticoagulation therapy for venous thromboembolism in patients with gynaecologic malignancy
5. Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy
6. Secondary prevention of venous thromboembolism: A role for low-molecular-weight heparin
7. The efficacy and safety of oral anticoagulation in patients with cancer
8. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer
9. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)
10. Thrombotic events during oral anticoagulant treatment: Results of the inception-cohort, prospective, collaborative ISCOAT study
11. A method to determine the optimal intensity of oral anticoagulant therapy
12. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy - Risk analysis using Medicare claims data
13. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester, Minnesota
14. The long-term clinical course of acute deep venous thrombosis
15. Trousseau's syndrome and other manifestations of chronic disseminated coagulapathy in patients with neoplasms: Clinical, pathophysiologic, and therapeutic features
16. Trousseau's syndrome. Devastating coagulopathy in the absence of heparin
17. Causes of death in cancer patients